Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Articles

Drug Shortages Continue to Plague FDA, Manufacturers

The more serious shortages commonly involve sterile injectables.

Preparing for the End of the COVID Health Emergency

Areas of focus during phase-out include telehealth and patient access.

Kudos and Hurdles for Industry, FDA in Tackling Rare Diseases

Taking stock as the Orphan Drug Act hits its 40-year anniversary.

Pandemic Alters Policies and Practices for Drug Development

COVID vaccine development highlights need for modernization.

Drug Prices Targeted in Biden Executive Order

Sweeping competition initiative drills in on cost reduction.

FDA’s Pazdur Challenges Attack on Accelerated Approval Program

In response to continued criticism of FDA’s initiative to make promising new therapies available to seriously ill patients based on early clinical results, Richard Pazdur, director of FDA’s Oncology Center of Excellence, lashed out at the alarmists and urged continued support for this early access process.